Get updates delivered to you daily. Free and customizable.
CBS Philly
Pennsylvania to make the animal sedative xylazine a controlled substance
By The Associated PressCBS News Philadelphia Staff,
11 days ago
HARRISBURG, Pa. (AP) — Pennsylvania Gov. Josh Shapiro will sign legislation to criminalize the misuse of a powerful animal tranquilizer called xylazine that is showing up in supplies of illicit drugs and contributing to a growing number of human overdose deaths, his office said Wednesday.
Xylazine, which is being mixed into fentanyl and other illicit opioids, will remain legal for its intended use by veterinarians.
The bill received approval from the state House of Representatives and the Senate in the past week.
Under the bill, xylazine will be listed as a "schedule III" drug under Pennsylvania's controlled substance law, formalizing an order that Shapiro issued last year when Pennsylvania joined a growing list of states that were moving to restrict access to xylazine.
Xylazine is a prescription sedative used by veterinarians to safely handle and treat farm animals, wildlife, zoo animals and household pets such as cats and dogs. It has seeped into the drug supply in Philadelphia's Kensington neighborhood and elsewhere.
Officials say the pain-relieving, muscle-relaxing drug, sometimes referred to as "tranq," is often abused by being added to fentanyl and heroin. It was detected in 3,000 U.S. drug deaths in 2021, according to the federal Drug Enforcement Administration.
The illicit use of schedule III drugs carries a penalty of imprisonment of up to five years. The law would require that the drug be stored safely when used professionally, to prevent theft or improper access.
Advocates have said labeling the drug as schedule III is not enough to stop the crisis.
Xylazine can cause breathing and heart rates to fall to dangerous levels when used in humans. When injected it can cause large open sores and infections, sometimes leading to amputation.
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0